Joseph P. Hagan
2010 - Orexigen Therapeutics
In 2010, Joseph P. Hagan earned a total compensation of $974K as Chief Business Officer at Orexigen Therapeutics, a 72% increase compared to previous year.
Compensation breakdown
| Bonus | $300,000 |
|---|---|
| Option Awards | $366,495 |
| Salary | $300,000 |
| Other | $7,470 |
| Total | $973,965 |
Hagan received $366.5K in option awards, accounting for 38% of the total pay in 2010.
Hagan also received $300K in bonus, $300K in salary and $7.5K in other compensation.
Rankings
In 2010, Joseph P. Hagan's compensation ranked 5,398th out of 10,439 executives tracked by ExecPay. In other words, Hagan earned more than 48.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,398 out of 10,439 | 48th |
Division Manufacturing | 1,946 out of 3,838 | 49th |
Major group Chemicals And Allied Products | 408 out of 921 | 56th |
Industry group Drugs | 242 out of 680 | 64th |
Industry Pharmaceutical Preparations | 184 out of 481 | 62nd |
Source: SEC filing on April 23, 2013.
Hagan's colleagues
We found five more compensation records of executives who worked with Joseph P. Hagan at Orexigen Therapeutics in 2010.
2010
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2010
Heather Turner
Orexigen Therapeutics
General Counsel
2010
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2010
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
2010
Preston Klassen
Orexigen Therapeutics
Head of Global Contrave Program and Senior Vice President, Product Development
News
Regulus Therapeutics CEO Joseph Hagan's 2021 pay falls 22% to $1.8M
April 27, 2022
Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
April 29, 2020
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019